British 7.7495933
ĠBi 9.123531
otech 3.242978
ĠPl 6.5211234
c 0.077423364
, 2.4812126
Ġa 1.5783678
Ġrenowned 9.879962
Ġpharmaceutical 3.5813036
Ġcompany 0.5213769
, 0.5472025
Ġhas 1.2254058
Ġrecently 4.0716357
Ġgenerated 7.4269834
Ġconsiderable 3.8405547
Ġexcitement 3.5741928
Ġin 1.9859385
Ġthe 0.34112534
Ġmedical 3.5022132
Ġfield 2.5485344
Ġwith 1.5123115
Ġits 1.1637826
Ġpromising 6.8448668
Ġcancer 5.503789
Ġdrug 1.4881952
, 1.2953163
ĠMar 7.8569813
im 5.4213595
ast 6.379645
at 0.5581614
. 0.7511519
ĠThough 6.4669785
Ġthe 1.182832
Ġdrug 1.2940018
Ġdisplays 8.472954
Ġsignificant 3.1632745
Ġpotential 2.2210746
, 1.7749066
Ġseveral 5.407352
Ġconsiderable 9.45444
Ġhurdles 1.857398
Ġremain 1.2896357
Ġon 5.858577
Ġthe 0.8809853
Ġpath 1.7679352
Ġto 0.6835762
Ġblockbuster 9.107596
Ġsuccess 1.5899788
. 0.2975313
Ċ 1.3033495
Mar 13.649082
im 0.029839134
ast 0.0019239378
at 0.001572788
, 2.2886932
Ġan 2.7101471
Ġinnovative 5.3077326
Ġmatrix 9.987276
Ġmet 1.7829436
all 0.5843681
op 0.045711134
rotein 0.068732895
ase 0.067398906
Ġinhibitor 0.21603
, 1.1874005
Ġhas 1.5280485
Ġshown 3.336214
Ġremarkable 3.41671
Ġefficacy 2.5319948
Ġin 0.4839183
Ġpre 3.6738396
clinical 0.5864807
Ġand 1.7273712
Ġearly 4.511064
- 2.2223306
stage 0.410407
Ġclinical 0.92017525
Ġtrials 0.6712532
, 1.817372
Ġpotentially 6.8036003
Ġrevolution 3.7665493
izing 0.1489022
Ġcancer 2.7416222
Ġtreatment 0.82190347
. 0.6325203
ĠBy 5.8415036
Ġinhib 4.127007
iting 0.00043295536
Ġenzymes 5.8873477
Ġcrucial 5.7933803
Ġfor 0.7677898
Ġtumor 2.6047952
Ġgrowth 0.79996485
Ġand 1.6958466
Ġprogression 2.7045598
, 0.096316844
ĠMar 0.6810077
im 0.0005583038
ast 0.000650988
at 0.000769626
Ġhas 2.2187672
Ġdemonstrated 3.04322
Ġan 3.2114394
Ġability 3.109224
Ġto 0.01057362
Ġimpede 8.17725
Ġthe 1.2001877
Ġspread 3.5306494
Ġof 0.08134001
Ġvarious 5.376471
Ġcancer 1.6034591
Ġtypes 1.1488583
. 1.4224974
ĠThis 3.0149674
Ġbreakthrough 3.9152887
Ġhas 2.2038555
Ġraised 3.65776
Ġhopes 1.7035285
Ġof 1.9109038
Ġimproved 6.376143
Ġpatient 4.040891
Ġoutcomes 0.64952433
Ġand 1.1839864
Ġa 2.5684128
Ġhigher 4.7857714
Ġquality 1.3374975
Ġof 0.027727952
Ġlife 0.033154555
Ġfor 1.2320328
Ġthose 2.837943
Ġaffected 2.2303095
Ġby 0.24779792
Ġcancer 0.32243577
. 0.17907855
Ċ 0.68779767
Despite 7.9745865
Ġthese 2.3741918
Ġpromising 1.1371473
Ġresults 1.2704227
, 0.09650351
ĠBritish 7.603395
ĠBi 0.06457803
otech 0.0044325073
ĠPl 1.0733285
c 0.0007324648
Ġfaces 2.9689066
Ġsignificant 2.5875003
Ġchallenges 0.7169534
Ġin 0.9788934
Ġtransforming 6.6667075
ĠMar 1.9876912
im 0.0005966542
ast 0.0004927634
at 0.00034989417
Ġfrom 1.831129
Ġa 0.47293025
Ġpromising 1.5623597
Ġdrug 1.748041
Ġcandidate 4.876336
Ġinto 0.50347644
Ġa 0.16611809
Ġworld 5.016137
- 0.12352193
leading 3.7280755
Ġblockbuster 3.7345362
. 1.0847687
ĠOne 4.0207124
Ġof 0.6066696
Ġthe 0.458404
Ġprimary 2.9700677
Ġobstacles 1.5244005
Ġlies 3.7395928
Ġin 0.17479162
Ġobtaining 4.6029363
Ġregulatory 1.2973597
Ġapproval 0.28849384
. 2.3972363
ĠThe 2.077216
Ġdrug 2.9772744
's 2.8838174
Ġsafety 3.7896872
Ġprofile 1.7156633
Ġand 1.9242587
Ġefficacy 1.4401873
Ġdata 3.3551335
Ġmust 4.0140624
Ġwithstand 7.4169583
Ġrigorous 0.90719444
Ġscrutiny 1.8572052
Ġfrom 2.7084746
Ġregulatory 1.3623966
Ġbodies 1.4780722
Ġsuch 2.6575074
Ġas 0.0039850785
Ġthe 0.08881976
ĠMedic 5.8048306
ines 0.0032929368
Ġand 0.074948356
ĠHealthcare 0.12313396
Ġproducts 0.73919547
ĠRegulatory 0.0057732924
ĠAgency 0.0094051985
Ġ( 0.24850193
MH 0.071204595
RA 0.0015597717
). 0.7785654
ĠWhile 3.7227707
Ġpre 7.199773
clinical 0.28836015
Ġtrials 3.1173306
Ġindicate 3.8847468
Ġpositive 4.8212523
Ġresults 0.7016901
, 0.4599228
Ġfurther 3.8737066
Ġclinical 1.7440675
Ġstudies 2.0462775
Ġinvolving 6.3094974
Ġa 2.7342737
Ġlarger 0.7467846
Ġpool 5.6638455
Ġof 0.0043137926
Ġpatients 0.33564106
Ġare 1.1417048
Ġnecessary 2.5651789
. 2.3970222
ĠThese 4.2405396
Ġtrials 2.7785935
Ġcan 4.1527886
Ġbe 1.6965078
Ġcostly 2.8140671
Ġand 0.36076188
Ġtime 0.6373231
- 0.7135189
consuming 0.011445651
, 0.6688611
Ġwhich 3.1307573
Ġmay 2.7288082
Ġhinder 3.0194955
Ġthe 0.72757745
Ġdrug 3.0770826
's 0.07992041
Ġprogress 3.8293805
Ġtowards 3.6842608
Ġregulatory 3.995811
Ġapproval 0.06389027
. 0.06438554
Ċ 1.3401368
Furthermore 5.646417
, 0.002461558
Ġcompetition 6.805762
Ġwithin 4.5060353
Ġthe 0.13617699
Ġpharmaceutical 1.6127259
Ġindustry 0.16838692
Ġposes 4.485935
Ġa 1.4983766
Ġformidable 3.0620408
Ġhurdle 2.7577982
. 1.4409573
ĠSeveral 3.799483
Ġestablished 5.2136593
Ġplayers 2.7386925
, 2.0586216
Ġarmed 12.190776
Ġwith 0.0038346478
Ġtheir 4.1099944
Ġown 1.5686651
Ġcutting 7.2448506
- 0.21254978
edge 0.001155999
Ġcancer 5.14509
Ġtreatments 2.344922
, 0.26027998
Ġare 1.2335703
Ġvying 2.5608947
Ġfor 0.29332733
Ġdominance 5.6318765
Ġin 0.5414406
Ġthe 0.23864368
Ġmarket 1.0300937
. 0.3738005
ĠBritish 3.5032222
ĠBi 0.011970682
otech 0.0013678017
ĠPl 0.06782645
c 0.0002014371
Ġmust 3.622006
Ġnavigate 4.269485
Ġthrough 2.2261403
Ġthis 1.6330659
Ġcompetitive 1.5893656
Ġlandscape 1.3084371
, 2.2732987
Ġdistinguishing 10.346866
ĠMar 5.553685
im 0.0003906776
ast 0.00045418294
at 7.4104384e-05
's 2.6807535
Ġunique 1.3268557
Ġselling 6.8925667
Ġproposition 0.9566829
Ġand 1.2975662
Ġestablishing 4.4370756
Ġits 1.954637
Ġsuperiority 5.273541
Ġover 0.82332885
Ġexisting 3.683075
Ġalternatives 4.3795085
. 0.21271123
ĠThis 3.3689723
Ġrequires 3.19247
Ġsubstantial 5.2904077
Ġinvestments 2.168205
Ġin 0.79130137
Ġmarketing 3.6013231
, 0.8497955
Ġclinical 3.4431212
Ġtrials 1.6776124
, 0.47934973
Ġand 0.5108112
Ġinfrastructure 5.306405
Ġto 2.1995335
Ġeffectively 5.3517203
Ġpromote 4.65391
Ġand 1.530069
Ġdistribute 3.3532193
Ġthe 0.58099884
Ġdrug 0.15633462
. 0.47794798
Ċ 1.1449496
Additionally 6.413234
, 0.0025560313
Ġfinancial 6.5912123
Ġconsiderations 3.2117236
Ġrepresent 6.9350505
Ġanother 1.2088797
Ġchallenge 3.2969007
Ġfor 2.3852887
ĠBritish 0.9584416
ĠBi 0.0053379694
otech 0.00053683587
ĠPl 0.03140986
c 0.00020131696
. 0.260547
ĠThe 1.716364
Ġcosts 5.1181326
Ġassociated 1.5219754
Ġwith 0.0044101747
Ġclinical 3.8146718
Ġtrials 0.23330587
, 1.5754398
Ġmanufacturing 3.4801846
, 0.46996933
Ġmarketing 2.468963
, 0.113884926
Ġand 0.25639766
Ġobtaining 6.401659
Ġregulatory 0.13399659
Ġapprovals 1.6171355
Ġdemand 6.387008
Ġsubstantial 1.3047502
Ġfunding 3.2078662
. 0.7080154
ĠInvestments 8.631287
Ġmust 3.1869254
Ġbe 0.20974188
Ġsecured 5.9133596
Ġto 2.4318793
Ġmeet 3.8589783
Ġthese 1.0034721
Ġdemands 3.4415238
, 0.9554481
Ġeither 6.249213
Ġthrough 0.4734709
Ġpartnerships 5.424863
, 2.6666179
Ġlicensing 3.9830194
Ġagreements 1.9813232
, 0.09176571
Ġor 0.23616812
Ġother 3.2333124
Ġfinancial 3.919326
Ġarrangements 0.77989584
. 0.12647858
ĠSec 9.754327
uring 0.016716579
Ġsufficient 4.496804
Ġfunding 0.86416
Ġis 2.0829961
Ġessential 2.8504615
Ġto 0.63133913
Ġsustain 4.080898
Ġthe 1.1496998
Ġdrug 3.3496747
's 0.1777402
Ġdevelopment 1.340293
Ġand 0.9378124
Ġreach 4.6160717
Ġthe 2.417387
Ġmarket 1.2149274
Ġeffectively 5.9971585
. 0.15199389
Ċ 1.0391514
Despite 4.488131
Ġthese 0.3663516
Ġhurdles 2.538282
, 0.060368747
ĠBritish 1.392563
ĠBi 0.00788051
otech 0.0006463342
ĠPl 0.022441482
c 0.00014360964
Ġremains 2.9366663
Ġoptimistic 1.743341
Ġabout 0.907831
ĠMar 1.5620685
im 0.00014074863
ast 0.0006041681
at 9.782879e-05
's 0.26295048
Ġfuture 2.8685472
Ġpotential 2.8965337
. 0.5541724
ĠThe 1.2648051
Ġcompany 0.9223712
's 1.4005545
Ġcommitment 3.887231
Ġto 0.06388296
Ġresearch 3.020091
Ġand 0.2874902
Ġdevelopment 0.1630931
, 1.5333867
Ġcoupled 2.956708
Ġwith 0.0017145193
Ġearly 7.4238443
Ġpositive 5.8880296
Ġindications 5.284552
, 1.1379726
Ġfost 9.609087
ers 0.09032218
Ġhope 2.332252
Ġfor 1.1126554
Ġa 1.302287
Ġsuccessful 2.5154157
Ġoutcome 3.634241
. 0.55153084
ĠHowever 4.7104697
, 0.004478788
Ġa 3.9246192
Ġconsiderable 6.5246315
Ġamount 0.80543053
Ġof 0.12172207
Ġtime 1.3915164
, 2.1391535
Ġdedication 5.186295
, 0.06896865
Ġand 0.08289317
Ġresources 2.027377
Ġwill 2.4419456
Ġdetermine 9.67611
ĠMar 2.54519
im 0.00026588395
ast 0.00039628413
at 0.000115950395
's 0.0030638603
Ġjourney 7.965401
Ġfrom 3.3827002
Ġan 3.5248613
Ġexciting 1.7489402
Ġprospect 3.6532137
Ġto 0.3805432
Ġa 0.3975025
Ġbreakthrough 4.00097
Ġblockbuster 2.8183384
Ġdrug 1.6779151
. 0.23867056
Ċ 1.1556304
In 3.0572178
Ġconclusion 2.7820237
, 0.014022969
ĠBritish 1.585022
ĠBi 0.009321685
otech 0.0016899823
ĠPl 0.042388886
c 0.00016292612
's 1.4966526
Ġcancer 7.483535
Ġdrug 0.3457688
ĠMar 1.575055
im 0.00016793102
ast 0.000604766
at 0.00012596205
Ġhas 1.5500095
Ġshown 2.7716944
Ġtremendous 2.6150067
Ġpromise 0.2924488
Ġin 1.1205791
Ġearly 3.827585
Ġtrials 5.006818
. 0.9244148
ĠHowever 1.7879325
, 0.009508631
Ġregulatory 4.4805064
Ġapproval 0.7392207
, 3.6832764
Ġthe 3.0014055
Ġcompetitive 6.282644
Ġlandscape 0.9322678
, 0.17896692
Ġand 0.22998194
Ġthe 1.3087466
Ġneed 3.3435838
Ġfor 0.5440808
Ġsubstantial 2.8326576
Ġfunding 1.1845343
Ġare 1.6601003
Ġsignificant 3.1066496
Ġobstacles 0.8755729
Ġthat 1.6051421
Ġmust 1.3915559
Ġbe 0.029800754
Ġovercome 0.14659792
Ġto 1.7149847
Ġbring 3.689453
ĠMar 1.2307843
im 0.00011213572
ast 0.000378156
at 0.0001010493
Ġto 0.3486483
Ġmarket 0.75516546
Ġsuccessfully 2.3655565
. 0.031980533
ĠThe 2.803893
Ġjourney 7.484819
Ġto 1.6414557
Ġbecoming 4.3635254
Ġa 0.30883497
Ġblockbuster 1.2656212
Ġdrug 0.4958248
Ġmay 2.580192
Ġbe 1.597276
Ġchallenging 2.5074928
, 0.4921992
Ġbut 0.06320328
Ġthe 1.5649887
Ġpotential 3.3642876
Ġbenefits 4.2765527
Ġfor 3.2363074
Ġcancer 2.2864294
Ġpatients 0.10799027
Ġmake 4.925492
Ġit 0.99389005
Ġa 1.7458302
Ġjourney 7.177985
Ġworth 0.20675378
Ġpursuing 1.9542805
. 0.07104607
